BioSig Technologies Inc
For the period ended Dec 31, 2024. Filed Apr 15, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Apr 15, 2025
STEX$0.37+8.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| BIOSIG TECHNOLOGIES, INC. | ||
| Date: April 15, 2025 | By: | /s/ Anthony Amato |
|---|---|---|
| Anthony Amato | ||
| Chief Executive Officer | ||
| Date: April 15, 2025 | By: | /s/ Ferdinand Groenewald |
| Ferdinand Groenewald | ||
| Interim Chief Financial Officer | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.